奥翔药业：累计回购约200万股

Group 1 - The company, Aoxiang Pharmaceutical, announced on July 31 that it has repurchased approximately 2 million shares through centralized bidding, accounting for 0.24% of its total share capital, with a total expenditure of about 15.54 million yuan [2] - The highest price for the repurchased shares was 8.57 yuan per share, while the lowest price was 7.52 yuan per share [2] - For the fiscal year 2024, the company's revenue composition is as follows: raw materials and intermediates account for 95.25%, while technical service fees account for 4.75% [2]